[1]
Zaniuk, M. et al. 2021. Ocrelizumab as a breakthrogh in multiple sclerosis treatment. Journal of Education, Health and Sport. 11, 5 (May 2021), 50–56. DOI:https://doi.org/10.12775/JEHS.2021.11.05.005.